Targeted gadofullerene for sensitive magnetic resonance imaging and risk-stratification of breast cancer
Open Access
- 25 September 2017
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 8 (1), 1-9
- https://doi.org/10.1038/s41467-017-00741-y
Abstract
Molecular imaging of cancer biomarkers is critical for non-invasive accurate cancer detection and risk-stratification in precision healthcare. A peptide-targeted tri-gadolinium nitride metallofullerene, ZD2-Gd3N@C80, is synthesised for sensitive molecular magnetic resonance imaging of extradomain-B fibronectin in aggressive tumours. ZD2-Gd3N@C80 has superior r 1 and r 2 relaxivities of 223.8 and 344.7 mM−1 s−1 (1.5 T), respectively. It generates prominent contrast enhancement in aggressive MDA-MB-231 triple negative breast cancer in mice at a low dose (1.7 µmol kg−1, 1 T), but not in oestrogen receptor-positive MCF-7 tumours. Strong tumour contrast enhancement is consistently observed in other triple negative breast cancer models, but not in low-risk slow-growing tumours. The dose of the contrast agent for effective molecular MRI is only slightly higher than that of ZD2-Cy5.5 (0.5 µmol kg−1) in fluorescence imaging. These results demonstrate that high-sensitivity molecular magnetic resonance imaging with ZD2-Gd3N@C80 may provide accurate detection and risk-stratification of high-risk tumours for precision healthcare of breast cancer.Keywords
This publication has 37 references indexed in Scilit:
- Molecular imaging of the tumor microenvironmentAdvanced Drug Delivery Reviews, 2017
- Biomedical Applications of Metal‐Encapsulated Fullerene NanoparticlesSmall, 2016
- Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancerNature, 2015
- Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass SpectroscopyRadiology, 2015
- Peptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRIBiomaterials, 2013
- Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition processProceedings of the National Academy of Sciences, 2011
- Safety and Tolerability of Ultrasmall Superparamagnetic Iron Oxide Contrast AgentInvestigative Radiology, 2009
- 212Pb@C60and Its Water-Soluble Derivatives: Synthesis, Stability, and Suitability for RadioimmunotherapyJournal of the American Chemical Society, 2007
- Carbon Nanostructures as a New High-Performance Platform for MR Molecular ImagingPublished by Springer Nature ,2007
- Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imagingNature Medicine, 1998